Publications by authors named "Mike Mattie"

Claim this Profile
M
Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma.
Nira Krasnow, Katie Maurer, Catherine Song, Justin Rhoades, Kan Xiong, Mike Mattie

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma.
Assia Hijazi, Frederick L Locke, Nathalie Scholler, Mike Mattie, Simone Filosto

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma.
Soumya Poddar, Jiali Yan, Gayatri Tiwari, Darawan Rinchai, Justin Budka, Mike Mattie

J Clin Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data.
Kelly Speth, Jin Xie, Qinghua Song, Mike Mattie, Jenny J Kim

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma.
Kun Yun, R Leo Sakemura, Ismail Can, Omar Gutierrez Ruiz, Ekene J Ogbodo, Mike Mattie

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire.
Giulia Cheloni, Dimitra Karagkouni, Yered Pita-Juarez, Daniela Torres, Eleni Kanata, Mike Mattie

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.
Jennifer J Gile, Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal, Mike Mattie

Exp Hematol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma.
Katie Maurer, Isabella N Grabski, Roch Houot, Satyen H Gohil, Shogo Miura, Mike Mattie

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy.
Yoganand Balagurunathan, Zhouping Wei, Jin Qi, Zachary Thompson, Erin Dean, Mike Mattie

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-4 drives exhaustion of CD8 CART cells.
Carli M Stewart, Elizabeth L Siegler, R Leo Sakemura, Michelle J Cox, Truc Huynh, Mike Mattie

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling.
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Mike Mattie

Nat Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling.
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Mike Mattie

Nat Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.
Rawan G Faramand, Sae Bom Lee, Michael D Jain, Biwei Cao, Xuefeng Wang, Mike Mattie

Blood Cancer Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma.
Frederick L Locke, Simone Filosto, Justin Chou, Saran Vardhanabhuti, Regis Perbost, Mike Mattie

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.
Michael D Jain, David B Miklos, Caron A Jacobson, John M Timmerman, Jennifer Sun, Mike Mattie

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T manufactured from frozen PBMC yield efficient function with prolonged production.
Julieta Abraham-Miranda, Meghan Menges, Reginald Atkins, Mike Mattie, Justyna Kanska

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.
Gabrielle Romain, Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan N Bandey, Mike Mattie

J Clin Invest· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.
Nathalie Scholler, Regis Perbost, Frederick L Locke, Michael D Jain, Sarah Turcan, Mike Mattie

Nat Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort Study.
Felix Korell, Olaf Penack, Mike Mattie, Nicholas Schreck, Axel Benner

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics.
Mike Mattie, Ashley Christensen, Mi Sook Chang, William Yeh, Suzanne Said

Neoplasia· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.
June M Chan, Vivian Weinberg, Mark J Magbanua, Eduardo Sosa, Jeffry Simko, Mike Mattie

Cancer Causes Control· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis